Fleury profit rises to R$96.3 million in 4Q25 as diagnostics demand grows
Revenue climbs 12% year-on-year while EBITDA reaches R$455.9 million, supported by B2C expansion and acquisitions.
Revenue climbs 12% year-on-year while EBITDA reaches R$455.9 million, supported by B2C expansion and acquisitions.